Catalyst Pharmaceuticals And SERB Reach Settlement With Hetero Labs Allowing Generic FIRDAPSE Entry No Earlier Than January 2035 Clearing All Pending Patent Litigation

Benzinga Newsdesk www.benzinga.com Positive 76.3%

Neg 0% Neu 0% Pos 76.3%

Comments

No comments yet. Be the first!